Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudipta Sonar

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Pathogens (Basel, Switzerland)|January 8, 2025
Pandemic-Proofing: Intercepting Zoonotic Spillover EventsBharti Bhatia, Sudipta Sonar, Seema Khan, et al.
Life Sciences|May 31, 2025
Unraveling cervical inflammation in HIV-infected women: The regulatory role of miR-204-5p and miR-3691-3pKadambari Akolkar, Sudipta Sonar, Amrita Rao, et al.
Frontiers in Immunology|June 10, 2021
Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse ModelTripti Shrivastava, Balwant Singh, Zaigham Abbas Rizvi, et al.
Plos Computational Biology|September 13, 2021
Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2Abhisek Dwivedy, Richard Mariadasse, Mohammed Ahmad, et al.
International Journal of Biological Macromolecules|June 29, 2023
Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infectionsShailendra Mani, Anupamjeet Kaur, Kamini Jakhar, et al.
3 Biotech|August 5, 2022
Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2Sonal Garg, Nisha Raj, Asha Lukose, et al.
International Journal of Biological Macromolecules|August 26, 2024
Targeting host inducible-heat shock protein 70 with PES-Cl is a promising antiviral strategy against SARS-CoV-2 infection and pathogenesisPrerna Joshi, Swati Garg, Shailendra Mani, et al.
Viruses|January 28, 2026
Serological Assays to Measure Rabies Antibody Response in Equine Serum SamplesNisha Beniwal, Banwari Lal, Sushma Mithina, et al.
International Immunopharmacology|October 14, 2021
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41Reshma Perween, Murugavelu PraveenKumar, Tripti Shrivastava, et al.
International Immunopharmacology|August 24, 2021
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virusPraveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pathogens (Basel, Switzerland)|January 8, 2025
Pandemic-Proofing: Intercepting Zoonotic Spillover EventsBharti Bhatia, Sudipta Sonar, Seema Khan, et al.
Life Sciences|May 31, 2025
Unraveling cervical inflammation in HIV-infected women: The regulatory role of miR-204-5p and miR-3691-3pKadambari Akolkar, Sudipta Sonar, Amrita Rao, et al.
Frontiers in Immunology|June 10, 2021
Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse ModelTripti Shrivastava, Balwant Singh, Zaigham Abbas Rizvi, et al.
Plos Computational Biology|September 13, 2021
Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2Abhisek Dwivedy, Richard Mariadasse, Mohammed Ahmad, et al.
International Journal of Biological Macromolecules|June 29, 2023
Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infectionsShailendra Mani, Anupamjeet Kaur, Kamini Jakhar, et al.
3 Biotech|August 5, 2022
Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2Sonal Garg, Nisha Raj, Asha Lukose, et al.
International Journal of Biological Macromolecules|August 26, 2024
Targeting host inducible-heat shock protein 70 with PES-Cl is a promising antiviral strategy against SARS-CoV-2 infection and pathogenesisPrerna Joshi, Swati Garg, Shailendra Mani, et al.
Viruses|January 28, 2026
Serological Assays to Measure Rabies Antibody Response in Equine Serum SamplesNisha Beniwal, Banwari Lal, Sushma Mithina, et al.
International Immunopharmacology|October 14, 2021
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41Reshma Perween, Murugavelu PraveenKumar, Tripti Shrivastava, et al.
International Immunopharmacology|August 24, 2021
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virusPraveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava, et al.
Pageof 2